98 related articles for article (PubMed ID: 1849613)
1. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Amirav I; Pawlowski N
N Engl J Med; 1991 May; 324(18):1288. PubMed ID: 1849613
[No Abstract] [Full Text] [Related]
2. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.
Manning PJ; Watson RM; Margolskee DJ; Williams VC; Schwartz JI; O'Byrne PM
N Engl J Med; 1990 Dec; 323(25):1736-9. PubMed ID: 2174121
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.
Margolskee DJ
Ann N Y Acad Sci; 1991; 629():148-56. PubMed ID: 1659276
[No Abstract] [Full Text] [Related]
4. Regulation of the production and action of leukotrienes by MK-571 and MK-886.
Ford-Hutchinson AW
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():9-16. PubMed ID: 1847788
[No Abstract] [Full Text] [Related]
5. MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.
Kips JC; Joos GF; De Lepeleire I; Margolskee DJ; Buntinx A; Pauwels RA; Van der Straeten ME
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):617-21. PubMed ID: 1892302
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.
Jones TR; Zamboni R; Belley M; Champion E; Charette L; Ford-Hutchinson AW; Gauthier JY; Leger S; Lord A; Masson P
Can J Physiol Pharmacol; 1991 Dec; 69(12):1847-54. PubMed ID: 1666333
[TBL] [Abstract][Full Text] [Related]
7. WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactions.
Weichman BM; Berkenkopf JW; Grimes D; Heaslip RJ; Sturm RJ; Chang JY
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():477-80. PubMed ID: 1847784
[No Abstract] [Full Text] [Related]
8. Development of novel leukotriene--based anti-asthma drugs: MK-886 and MK-571.
Young RN
Agents Actions Suppl; 1991; 34():179-87. PubMed ID: 1793062
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma.
Rasmussen JB; Eriksson LO; Margolskee DJ; Tagari P; Williams VC; Andersson KE
J Allergy Clin Immunol; 1992 Aug; 90(2):193-201. PubMed ID: 1323587
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilation with a potent and selective leukotriene D4 (LTD4) receptor antagonist (MK-571) in patients with asthma.
Gaddy JN; Margolskee DJ; Bush RK; Williams VC; Busse WW
Am Rev Respir Dis; 1992 Aug; 146(2):358-63. PubMed ID: 1489125
[TBL] [Abstract][Full Text] [Related]
11. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
Blain JF; Sirois P
Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
[TBL] [Abstract][Full Text] [Related]
12. Stereospecific synthesis, assignment of absolute configuration, and biological activity of the enantiomers of 3-[[[3-[2-(7-chloroquinolin-2-yl)-(E)-ethenyl]phenyl] [[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid, a potent and specific leukotriene D4 receptor antagonist.
Gauthier JY; Jones T; Champion E; Charette L; Dehaven R; Ford-Hutchinson AW; Hoogsteen K; Lord A; Masson P; Piechuta H
J Med Chem; 1990 Oct; 33(10):2841-5. PubMed ID: 2170650
[TBL] [Abstract][Full Text] [Related]
13. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
Wong WS; Zhu H; Liao W
Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene (LT) D4 is involved in antigen-induced asthma: a study with the LTD4 receptor antagonist, MK-571.
Rasmussen JB; Margolskee DJ; Eriksson LO; Williams VC; Andersson KE
Ann N Y Acad Sci; 1991; 629():436. PubMed ID: 1952571
[No Abstract] [Full Text] [Related]
15. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
16. Effects of timolol, indomethacin, and MK-571 on bronchoconstriction to infused leukotriene D4 in guinea pigs.
Masson P; Jones TR
Can J Physiol Pharmacol; 1990 Jul; 68(7):783-90. PubMed ID: 2383794
[TBL] [Abstract][Full Text] [Related]
17. Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist.
Finnerty JP; Wood-Baker R; Thomson H; Holgate ST
Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):746-9. PubMed ID: 1554195
[TBL] [Abstract][Full Text] [Related]
18. Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.
Wahedna I; Wisniewski AS; Tattersfield AE
Br J Clin Pharmacol; 1991 Oct; 32(4):512-5. PubMed ID: 1958449
[TBL] [Abstract][Full Text] [Related]
19. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
20. [Peptidoleukotriene receptor antagonists in asthma therapy].
Sakakibara H; Hirose K; Okawara S
Nihon Rinsho; 1996 Nov; 54(11):3049-55. PubMed ID: 8950953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
